Abstract 33
To examine the functional contribution of Inflammatory Bowel Disease (IBD) microbes to 34 immune homeostasis and colitis, we colonized unchallenged and colitis-susceptible germ-35 free mice with over twenty human intestinal microbiotas from healthy and IBD donors. 36
Compared to healthy microbiotas, IBD microbiotas led to expanded RORγt + Th17 cells and 37 reduced RORγt + Treg in the gut of unchallenged gnotobiotic mice and increased disease 38 severity in colitis-susceptible mice. The proportions of RORγt + Th17 and RORγt + Treg 39 induced by each microbiota were highly predictive of the human disease status and 40 strongly correlated with disease severity in colitis-susceptible mice colonized with the 41 same human microbiotas. The transmittable functional potential of IBD microbes suggests 42 a mechanism for a microbial contribution to IBD pathogenesis and a potential route for its 43 treatment and prevention. 44 unknown but essential question to translate the results of microbiome research to health 48 benefits. Numerous animal models suggest the microbial strains that constitute the gut 49 microbiota play a crucial role in shaping the immune system, consequentially influencing 50 host susceptibility to autoimmunity, inflammatory disease and infection [2] [3] [4] [5] . Inflammatory 51 bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is 52 associated with an altered intestinal microbiota [6] [7] [8] and genetic defects in microbial 53
handling are implicated in disease [9] . Therefore, interventions targeting the microbiota 54 are a potential path for IBD treatment [10, 11] . Humanized gnotobiotic animals can be 55 used to test causative relationships between human microbiomes and host physiology 56 while maintaining control over host genetics, diet and environment [12] [13] [14] [15] [16] . Components 57 of IBD-associated microbiotas can enhance colitis severity in gnotobiotic mice [17] [18] [19] [20] , 58 and complete microbiotas from donors both with and without IBD can induce intestinal 59 inflammation in susceptible mice [19, [21] [22] [23] [24] . However, the scale of these studies has 60 precluded identifying specific functional consequences to the host of colonization with IBD 61 microbiotas compared to healthy microbiotas. Here we use 30 human gut microbiotas 62 from two independent cohorts recruited near New York, NY or near Los Angeles, CA, to 63 demonstrate that IBD microbiotas drive distinct immune profiles in unchallenged 64 gnotobiotic mice and more severe disease in colitis-susceptible gnotobiotic mice. 65
66
Since IBD pathophysiology is associated with a dysregulated T cell response [25], we 67 asked whether IBD microbiotas could specifically alter CD4 T cell responses compared to 68 healthy microbiotas. Thus we colonized germ free C57Bl/6J (B6) mice with fecal slurries 69 or arrayed cultured fecal microbiota collections [26, 27] from two independent cohorts of 70 healthy donors (n=11) or donors with IBD (n=13; Table S1) [8] . Four to six weeks post 71 colonization, we performed a comprehensive measurement of CD4 + T helper (Th) and T 72 regulatory (Treg) cells in the intestinal lamina propria of each colonized mouse using flow 73 cytometry. While we found no difference in the proportion of IFNγ + Th1, GATA3 + Th2, IL-74 10 + or IL-17A + CD4 T cells ( Fig.1, S1 ), the average proportion of RORγt + Th (CD4 + Foxp3 -75 RORγt + ) induced by IBD microbiotas was significantly higher than healthy donor-derived 76 microbiotas in both colon and ileum (p=0.009, p=0.034 respectively; t-test; Fig. 1C , S2). 77 RORγt + Th varied over an 6-fold range and included human microbiotas inducing similar 78 proportions to common low/high Th17 reference communities (specific pathogen free 79 (SPF) mouse microbiotas +/-segmented filamentous bacteria (SFB)) [4] (Fig.1D ). The 80 proportion of RORγt + Th was correlated with the proportion of IL-17A + CD4 T-cells within 81 each tissue (colon; p=2.3x10 -6 , R 2 =0.68, ileum; p=0.0018, R 2 =0.36; Fig. S1G ). 82
83
We hypothesized that the specific expansion of RORγt + Th may be the result of impaired 84 FoxP3 + Treg induction by IBD-associated microbiotas. As in previous studies [26, 28] , the 85 majority of microbiotas led to an expansion of gut FoxP3 + Treg above baseline germ-free 86 levels ( Fig. 2A ). Although variation in the proportion of FoxP3 + Treg was significantly 87 influenced by donor microbiota (p=1.8x10 -10 (colon), p=4.9x10 -4 (ileum); ANOVA), we 88 observed no difference between the proportion of FoxP3 + Treg induced by healthy or IBD-89 associated microbiotas in colon or ileum ( Fig. 2B ). We also found no correlation between 90 the proportion of RORγt + Th and FoxP3 + Treg induced by each microbiota in either tissue 91 ( Fig. S3 ). Recently, the gut-specific subset of Treg that co-express FoxP3 and RORγt 92 (RORγt + Treg) was found to be microbiota-dependent and colitoprotective [29] [30] [31] [32] [33] . 93
Induction of RORγt + Treg varied significantly with different microbiotas (p<1x10 -5 ,ANOVA; 94
In contrast to the total Treg population, we observed a significant expansion of 95 RORγt + Treg induced by healthy relative to IBD microbiotas in both colon and ileum 96 (p<0.001, t-test; Fig. 2D -E). This difference was significant across both cultured and stool 97 microbiotas ( Fig.S4A ) and across the two independent cohorts of IBD patients (Fig. S4B) . 98
Of note, the proportion of total FoxP3 + Treg was only weakly correlated with RORγt + Treg 99 in ileum (p=0.012; R 2 =0.24) and uncorrelated in colon ( Fig. 2F ), suggestive of a unique 100 developmental pathway for RORγt + Treg. Helios + Treg were not differentially induced by 101 healthy and IBD microbiotas and we observed only a weak correlation between 102
RORγt + Treg and Helios + Treg (Fig. S5 ). It has been suggested that RORγt + Treg are 103 uniquely positioned to regulate Th2 responses [32] . Although we observed a non-104 significant expansion of Th2 (GATA3 + FoxP3 -CD4 + ) cells in the colon of gnotobiotic mice 105 colonized with IBD microbiotas relative to healthy microbiotas (p=0.051, t-test; Fig.1B) , 106 induction of Th2 cells was uncorrelated with RORγt + Treg (p=0.062, Fig.S5A ). We also 107 found no correlation between the proportion of RORγt + Treg and RORγt + Th or IFNγ + CD4 108
T-cells (Fig. S6B-C). 109 110
To assess if IBD-associated microbiotas influence colitogenesis, we tested healthy-and 111 IBD-donor microbiotas in a gnotobiotic mouse model of colitis. Given the known 112 importance of T-cells in IBD pathophysiology we chose a model of colitis that is both T 113 cell-and microbiota-dependent. Transfer of CD45RB HI (naïve) CD4 T-cells to Rag-114 deficient mice induces colitis-like pathology, but only in the presence of an immunogenic 115 microbiota (hereafter the Rag T-cell transfer, (RagTCT) model) [34, 35] . 4-8 weeks prior 116
to T-cell transfer, we colonized germ-free Rag1 -/mice with fecal microbiotas from both 117 healthy (n=16) or IBD human donors (n=14; see Data S1). As measured by loss in body 118 mass, histology, and elevation of fecal lipocalin2 (LCN2), colitis was more severe in mice 119 colonized with fecal microbiotas from individuals with IBD than those colonized with 120 microbiotas from healthy donors (p=4.2x10 -5 , p=0.0058 at day 42 respectively for body 121 mass and LCN2, t-test; Fig. 3 ). Loss in body mass was correlated with elevated fecal 122 LCN2 (R 2 =0.33, p=1.4x10 -7 ; Fig. S7 ). Remarkably, a significant difference in weight loss 123 between healthy and IBD microbiotas was already detectable 7 days after T-cell transfer 124 and became more prominent over time ( Fig. S8 ). There was no significant difference in 125 colitis severity between mice colonized with microbiotas from donors with UC compared 126 to CD (p=0.59, t-test; Fig. 3D ), and CD and UC microbiotas each independently induced 127 colitis that was more severe than in mice colonized with healthy donor microbiotas 128 (p<0.01, p<0.001 for UC and CD respectively, ANOVA; Fig. 3D ). We replicated these 129 findings in two independent cohorts of donors [8] (Fig. 3E, S9A ). We also found both stool 130 microbiotas and cultured collections of microbes from donors with IBD were similarly able 131 to increase colitis susceptibility in mice, relative to healthy donor microbiotas ( Fig. 3F , 132 S9B). For ten donors, we assayed the colitogenicity of both the stool and cultured 133 microbiota collection. Eight of the 10 cultured microbiotas transferred colitis of equivalent 134 severity as the total stool microbiota derived from the same donor ( Fig. S10) . 135 136 Finally, we sought to understand how the variation in CD4 T-cell responses we observed 137 in unchallenged gnotobiotic B6 mice correlated with colitis severity in RagTCT mice 138 colonized with the same donor microbiotas. A total of 9 healthy and 11 IBD microbiotas 139 were tested in both models (Table S1 ). While colitis severity was not correlated with 140
IFNγ + Th or FoxP3 + Treg (Fig. 4A-B ), the proportion of colon and ileum RORγt + Th induced 141 by a microbiota in B6 mice was positively correlated with colitis severity in RagTCT mice 142 colonized with the same microbiota (R 2 =0.46, p=9x10 -4 ; R 2 =0.34, p=0.006 for colon and 143 ileum respectively; Fig. 4C ). Induction of RORγt + Treg in B6 mice was inversely correlated 144 with colitis severity in RagTCT mice (R 2 =0.47, p=0.0007; R 2 =0.43, p=0.002 for colon and 145 ileum respectively; Fig. 4D ). The proportion of IL-17A + CD4 T-cells induced in colon was 146 also weakly associated with colitis severity (R 2 =0.26, p=0.015; Fig. S10A ). Colitis severity 147
was not associated with Helios + Treg, IL-10 + , or GATA3 + CD4 T-cells ( Fig. S11) . [BD], 1g/l each of D-xylose, D-fructose, D-glactose, cellubiose, maltose, sucrose, 0.5g/l N-184 acetylglucosamine, 0.5g/l L-arabinose, 0.5g/l L-cysteine, 1g/l malic acid, 2g/l sodium 185 sulfate, 0.05% Tween 80, 20µg/ml menadione, 5mg/l hemin (as histidine-hemitin), 0.1M 186 MOPS, pH 7.2). The slurries were passed through sterile 100µm strainers to remove 187 large debris. To store for later administration to mice, slurries were diluted 1:20 in 188
LYBHIv4 media containing 15% glycerol (final concentration) and stored at -80°C. 189
190
Arrayed culture collections were generated for selected donors as previously described. 191
Briefly, clarified and diluted donor stool was plated onto a variety of solid selective and 192 non-selective media under anaerobic, micro-aerophilic and aerobic conditions. Plates 193 were incubated for 48-72 hours at 37°C. 384 single colonies from each donor microbiota 194
were individually picked and regrown in liquid LYBHIv4 media for 48 hours under 195 anaerobic conditions. Regrown isolates were identified at the species level using a 196 combination of MALDI-TOF mass spectrometry (Bruker Biotyper) and 16S rDNA amplicon 197
sequencing. An average of 16 unique species were isolated from each fecal sample 198 (range 10-29; Table S2 ). There was no significant difference in the number of unique 199 isolates obtained from healthy donor and IBD donors (p=0.19, Mann-Whitney). All 200 regrown isolates were stored in LYBHIv4 with 15% glycerol at -80°C as both arrayed 201 culture collections in 96 well plates and pooled as a cocktail for administration to mice. 202 203
Gnotobiotic mice 204
Germ free C57Bl/6J and C57Bl/6J Rag1-deficient (B6.129S7-Rag1 tm1Mom /J) mice were 205 bred in-house at the Mount Sinai Immunology Institute Gnotobiotic Facility in flexible vinyl 206 isolators. To facilitate high-throughput studies in gnotobiotic mice we utilized "out-of-the-207
isolator" gnotobiotic techniques [26] . Shortly after weaning (28-42 days old) and under 208 strict aseptic conditions, germ-free mice were transferred to autoclaved filter-top cages 209 outside the of the breeding isolator and colonized with human microbiotas; Mice were 210 colonized with 200-300µl of a fecal slurry or pooled cocktail of cultured strains by oral 211 gavage, given only once. All experiments were performed at least 28 days after 212 colonization. All phenotyping experiments in B6 mice included both male and female mice. The composition of human and mouse fecal samples was analyzed by 16S rDNA amplicon 219 sequencing as previously described [37] [38] [39] . DNA was extracted by bead-beating followed 220 by QiaQuick columns (Qiagen) and quantified by Qubit assay (Life Tehcnologies). The V4 221 region of the 16S gene was amplified by PCR and paired-end 250bp reads sequenced on 222 an Ilumina MiSeq. Analysis was performed with MacQIIME 1.9.1.8 and custom R scripts. 223
OTUs were picked with 97% sequence similarity. OTUs were aligned to the Greengenes 224 reference set, requiring 150bp minimum sequence length and 75% ID. were restimulated in complete RPMI with 5ng/ml phorbal 12-myristate 13-acetate (PMA) 243 and 500ng/ml ionomycin in the presence of monensin (Biolegend) for 3.5 hours at 37°C. 244
Dead cells were excluded from all analyses using Zombie Aqua Fixable Viability dye 245 (Biolegend). For intracellular cytokine staining, cells were fixed with IC Fixation Buffer 246 (eBioscience) and transcription factors were detected in unstimulated cells fixed with 247
FoxP3 Fixation/Permeabilization buffers (eBioscience). Antibodies used in this study are 248 listed in Table S2 . All data was acquired on the same LSRII instrument (BD Biosceinces) 249 and analyzed using FloJoX (TreeStar) . 250
T cell transfer colitis 252
T cell transfer colitis experiments were performed as previously described [40] . Briefly, 253 naïve (CD45RB HI , CD25 -) CD4 T cells were isolated from the spleen and subcutaneous 254 lymphnodes of 7-9 week old specific pathogen free C57Bl/6J mice (The Jackson 255 Laboratory). Following tissue dissociation and red blood cell lysis CD4 + T cells were 256 enriched using negative magnetic selection (Magnisort, eBioscience). The resulting cells 257
were stained for expression of CD4, CD25 and CD45RB. A fraction representing ~50% of 258 the total CD4 + population, selected on the basis of absent CD25 staining and high 259 CD45RB staining was sorted using a FACSAria (BD Biosciences). Purity of the sorted 260 fraction was checked and routinely exceeded 98%. Sorted cells were washed multiple 261 times with sterile PBS. Gnotobiotic Rag1 -/mice received 1x10 6 CD45RB HI T cells in 200µl 262 of sterile PBS by intraperitoneal injection. Donor cells were sex-matched to recipients. 263
264
Mice were weighed and fecal pellets were collected at the time of T cell transfer and 265 weekly thereafter. Any mouse experiencing >80% loss in body weight or which was 266 deemed otherwise moribund was euthanized. In these cases, the last measurements of 267 body mass or LCN2 taken for that mouse were carried forward and included in the data 268 for subsequent time points. Inter-experimental variation was assessed across the screen 269 by including one cultured donor microbiota in each experiment. This donor (UC1024) 270
induced highly reproducible colitis in many repeats over ~2 years (Fig. S12 ). We set pre-271 determined exclusion criteria for any experiment where mice colonized with UC1024 did 272 not develop colitis in this reproducible manner. The mean proportion of FoxP3 + Treg induced by a donor microbiota is not significantly associated with the disease phenotype of the donor (ns -not significant; t-test). Each symbol represents the mean value from a group of 3-12 mice colonized with a single microbiota; horizontal lines indicate mean ± SEM. C. The proportion of RORγt + Treg in the colon and ileum of gnotobiotic mice colonized with fecal microbiotas from different human donors. Each symbol represents data from one mouse; horizontal lines indicate mean ± SEM. D. The mean proportion of RORγt + Treg in colon and ileum is increased in gnotobiotic mice colonized with healthy-donor microbiotas compared to IBD-donor microbiotas. Each symbol represents the mean value from a group of 3-12 mice colonized with a single microbiota; horizontal lines indicate mean ± SEM. n=11 healthy, 6 UC and 7 CD microbiotas ***p<0.001. E. Gating of RORγt + Treg and representative plots of colon RORγt + Treg in gntotobiotic mice colonized with six different microbiotas. F. Total FoxP3 + and RORγt + Treg are not significantly correlated in the colon and weakly correlated in the ileum. Each symbol represents the mean value from a group of 3-12 mice colonized with a single microbiota. Each thin line represents the mean data from a group of 5-15 mice colonized with a single microbiota (n=16 healthy donors assayed in a total 152 mice, n=12 IBD donors assayed in a total of 106 mice). Bold lines represent the mean ± SEM of all groups of mice colonized with either healthy donor or IBD donor microbiotas. C. Representative H&E stained colon sections from RagTCT mice colonized with different human donor microbiotas 5-7 weeks after T cell transfer. Scale bar = 200µm. D. We found no significant change in body mass loss between RagTCT mice colonized with human UC or CD microbiotas. Each point represents the mean weight change 6 weeks after T cell transfer of a group of 5-15 mice colonized with a single microbiota (n=6 CD donors, n=6 UC donors). Bold lines represent the mean ± SEM of all groups of mice colonized with either CD donor or UC donor microbiotas. E. IBD microbiotas from both donor cohorts induce more severe weight loss, as measured by weight loss at week 6, than healthy donor microbiotas. F. Cultured and stool IBD microbiotas both induce more severe weight loss, as measured by weight loss at week 6, than healthy donor microbiotas. **p<0.01, ****p<0.0001 
